Clinical Trial Update: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SURF-200 eye drop for episodic flares in Dry Eye Disease completed, comparing its effects to vehicle with safety and efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SURF-200

Snippet

Sponsor: Surface Ophthalmics, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-06-04